Valuation: Integra LifeSciences Holdings Corporation

Market Cap 1.54B 1.35B 1.25B 1.15B 2.17B 149B 2.21B 14.89B 5.85B 72.67B 5.8B 5.67B 251B P/E 2026 *
30.5x
P/E 2027 * 16.5x
Enterprise Value 2.88B 2.52B 2.33B 2.14B 4.05B 278B 4.12B 27.79B 10.92B 136B 10.83B 10.59B 468B EV / Sales 2026 *
1.72x
EV / Sales 2027 * 1.57x
Free-Float
72.36%
Yield 2026 *
-
Yield 2027 * -
1 day+5.70%
1 week+7.94%
Current month+10.52%
1 month+12.08%
3 months+83.12%
6 months+59.95%
Current year+59.82%
1 week 18.05
Extreme 18.05
20.26
1 month 17.01
Extreme 17.01
20.26
Current year 8.7
Extreme 8.7
20.26
1 year 8.7
Extreme 8.7
20.26
3 years 8.7
Extreme 8.7
46.75
5 years 8.7
Extreme 8.7
76.7
10 years 8.7
Extreme 8.7
77.4
Manager TitleAgeSince
Chief Executive Officer 64 01/05/2026
Director of Finance/CFO 54 28/06/2023
Chief Tech/Sci/R&D Officer - 17/02/2026
Director TitleAgeSince
Chairman 64 03/01/2012
Director/Board Member 81 01/01/1992
Director/Board Member 65 01/01/2006
Date Insider Type Main position Quantity % Market Cap.
3/7/26 Tax

Chief Financial Officer

-5,226 0.0067%
1/7/26 Free

Executive/Senior Manager

11,180 0.0144%
1/7/26 Free

Executive/Senior Manager

5,590 0.0072%
Change 5-day change 1-year change 3-year change Capi.($)
+5.70%+7.94%+64.05%-53.79% 1.54B
+10.71%+4.69%-24.98%-8.43% 172B
+3.84%+1.42%-6.93%-4.67% 107B
+3.85%+1.83%+3.41%+60.90% 59.92B
+3.26%+6.02%-10.29%-38.34% 44.07B
+4.23%+0.64% - - 34.76B
+7.22%+6.79%-7.31%-43.21% 30.09B
+0.96%+1.34%+61.53%-5.89% 25.61B
+0.37%+2.62%-2.49%-17.90% 20.86B
+4.57%+2.38%-2.85%-3.47% 21.55B
Average +3.13%+3.74%+8.24%-12.76% 51.75B
Weighted average by Cap. +2.05%+3.38%-8.18%-4.09%

Financials

2026 *2027 *
Net sales 1.68B 1.47B 1.35B 1.24B 2.35B 162B 2.39B 16.16B 6.35B 78.87B 6.29B 6.16B 272B 1.73B 1.51B 1.4B 1.28B 2.43B 167B 2.47B 16.68B 6.55B 81.41B 6.5B 6.35B 281B
Net income 42.73M 37.35M 34.54M 31.7M 59.99M 4.12B 61.03M 412M 162M 2.01B 160M 157M 6.94B 74.56M 65.18M 60.28M 55.31M 105M 7.19B 107M 719M 282M 3.51B 280M 274M 12.11B
Net Debt 1.34B 1.17B 1.08B 993M 1.88B 129B 1.91B 12.9B 5.07B 62.98B 5.03B 4.92B 217B 1.18B 1.03B 951M 872M 1.65B 113B 1.68B 11.34B 4.45B 55.33B 4.42B 4.32B 191B
Logo Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is a global medical technology company. It manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.
Employees
4,427
Date Price Change Volume
16/07/26 USD 19.85 +5.70% 1,316,629
15/07/26 USD 18.78 +2.07% 771,962
14/07/26 USD 18.40 -0.97% 1,070,166
13/07/26 USD 18.58 -1.12% 803,323
10/07/26 USD 18.79 +2.18% 951,869
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
11
Last Close Price
19.85USD
Average target price
18.62USD
Spread / Average Target
-6.17%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IART Stock